[go: up one dir, main page]

MX9205766A - COLON AND STRAIGHT CANCER TREATMENT - Google Patents

COLON AND STRAIGHT CANCER TREATMENT

Info

Publication number
MX9205766A
MX9205766A MX9205766A MX9205766A MX9205766A MX 9205766 A MX9205766 A MX 9205766A MX 9205766 A MX9205766 A MX 9205766A MX 9205766 A MX9205766 A MX 9205766A MX 9205766 A MX9205766 A MX 9205766A
Authority
MX
Mexico
Prior art keywords
colon
cancer treatment
straight
straight cancer
treatment
Prior art date
Application number
MX9205766A
Other languages
Spanish (es)
Inventor
Randall Keith Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9205766A publication Critical patent/MX9205766A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX9205766A 1991-12-10 1992-10-08 COLON AND STRAIGHT CANCER TREATMENT MX9205766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80457091A 1991-12-10 1991-12-10

Publications (1)

Publication Number Publication Date
MX9205766A true MX9205766A (en) 1993-06-01

Family

ID=25189304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205766A MX9205766A (en) 1991-12-10 1992-10-08 COLON AND STRAIGHT CANCER TREATMENT

Country Status (7)

Country Link
EP (1) EP0661977A1 (en)
JP (1) JPH07501818A (en)
AU (1) AU2394392A (en)
CA (1) CA2125293A1 (en)
MX (1) MX9205766A (en)
PT (1) PT100948A (en)
WO (1) WO1993011770A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
ES2114681T3 (en) * 1993-01-15 1998-06-01 Stehlin Foundation For Cancer TRANSDERMIC TREATMENT OF CANCER WITH INSOLUBLE CAMPTOTECINE IN WATER IN THE FORM OF CLOSED LACTON RING.
US6291425B1 (en) * 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
RU2160104C2 (en) * 1997-11-06 2000-12-10 Закрытое акционерное общество "Центр современной медицины "Медикор" Method and medicinal preparation for treating peptic ulcers
ES2371171B1 (en) * 2010-06-08 2012-11-16 Consejo Superior De Investigaciones Científicas (Csic) CAMPTOTECHINE DERIVATIVES AS ANTITUMOR AGENTS.
CN102477042A (en) * 2010-11-26 2012-05-30 复旦大学 10-hydroxycamptothecin derivative and preparation method and application thereof
CN102659800B (en) * 2012-05-11 2014-09-03 中国药科大学 Hypoxia-activated antitumor compounds and application thereof
CN103113381B (en) * 2013-02-26 2014-12-10 大连理工大学 A series of water-soluble hydroxycamptothecin cycloalkanol derivatives and their preparation methods and uses
TW202146055A (en) 2020-02-25 2021-12-16 美商麥迪波士頓股份有限公司 Camptothecin derivatives and conjugates thereof
CN117599058A (en) * 2023-03-09 2024-02-27 兰州大学 Application of camptothecin derivatives in the preparation of drugs for the treatment of bladder cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0641161B2 (en) * 1988-02-17 1994-06-01 積水化成品工業株式会社 Method for producing styrene resin foam sheet and styrene resin foam sheet for thermoforming
JPH0768403B2 (en) * 1988-12-15 1995-07-26 東洋エンジニアリング株式会社 Method of manufacturing foam
JP2756366B2 (en) * 1990-11-27 1998-05-25 松下電工株式会社 Method for producing hydrophobic airgel

Also Published As

Publication number Publication date
AU2394392A (en) 1993-07-19
PT100948A (en) 1994-01-31
EP0661977A4 (en) 1994-10-20
WO1993011770A1 (en) 1993-06-24
EP0661977A1 (en) 1995-07-12
CA2125293A1 (en) 1993-06-24
JPH07501818A (en) 1995-02-23

Similar Documents

Publication Publication Date Title
DE69120096D1 (en) Treated papers
FI970990A7 (en) Cancer detection and treatment
DE59406123D1 (en) HAIR TREATMENT
BR9303267A (en) TWO PASTA VILLANT
FI933121L (en) SOTHALTIGA PIGMENT
FI972484L (en) Carcinoma treatment
FI930487A0 (en) NYTT FLINGFORMIGT PIGMENT
FI931072L (en) YTMODIFIED PIGMENT
FI932933A0 (en) Tvaostegsraffinoer med variable intensity
FI951163A7 (en) Waste treatment
DE69031446D1 (en) IMAGE TREATMENT ARRANGEMENT
MX9205766A (en) COLON AND STRAIGHT CANCER TREATMENT
FI960658A7 (en) New bis-naphthalimides for cancer treatment
GB9303210D0 (en) Cancer treatment
DK206391A (en) SLUDGE TREATMENT
DE69125187D1 (en) WASTE TREATMENT
DE69218229D1 (en) DESULFURATION TREATMENT
DE69114853D1 (en) WASTEWATER TREATMENT.
DE69101652D1 (en) Treatment furnace.
MX9200725A (en) ESOPHAGEAL CANCER TREATMENT. ESOPHAGEAL CANCER TREATMENT.
GB2242372B (en) Sewage treatment
NO922518D0 (en) coagulants
DE69125179D1 (en) WASTEWATER TREATMENT
FI945200A7 (en) Wastewater treatment
KR970000602A (en) Antibacterial treatment of printed matter